Modulation of doxorubicin resistance in multidrug‐resistant cells by liposomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Modulation of doxorubicin resistance in multidrug‐resistant cells by liposomes

Published:1993-04 Issue:6 Volume:7 Page:572-579
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Thierry Alain R.¹,Vigé Dominique¹,Coughlin Steven S.²,Belli James A.³,Dritschilo Anatoly¹,Rahman Aquilur⁴

Affiliation:

1. Department of Radiation MedicineLombardi Cancer Research CenterGeorgetown University School of MedicineWashington, D.C.20007USA

2. Biostatistics and Epidemiology UnitLombardi Cancer Research CenterGeorgetown University School of MedicineWashington, D.C.20007USA

3. Department of Radiation TherapyUniversity of Texas Medical BranchGalvestonTexas77550USA

4. Department of MedicineLombardi Cancer Research CenterGeorgetown University School of MedicineWashington, D.C.20007USA

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fasebj.7.6.8097173

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer;Journal of Nanobiotechnology;2022-09-24

2. Chemophototherapy Overcomes Doxorubicin Resistance in Human Ovarian Cancer Cells;2022-02-16

3. Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children’s Oncology Group;Journal of Clinical Oncology;2020-07-01

4. DOX-loaded peptide dendritic copolymer nanoparticles for combating multidrug resistance by regulating the lysosomal pathway of apoptosis in breast cancer cells;Journal of Materials Chemistry B;2020

5. Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity;Beilstein Journal of Nanotechnology;2019-10-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3